Geode Capital Management’s Oramed Pharmaceuticals ORMP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54.6K | Sell |
24,282
-1,173
| -5% | -$2.64K | ﹤0.01% | 4198 |
|
|
2025
Q1 | $54.5K | Hold |
25,455
| – | – | ﹤0.01% | 4182 |
|
|
2024
Q4 | $61.6K | Hold |
25,455
| – | – | ﹤0.01% | 4207 |
|
|
2024
Q3 | $62.1K | Hold |
25,455
| – | – | ﹤0.01% | 4219 |
|
|
2024
Q2 | $65.4K | Hold |
25,455
| – | – | ﹤0.01% | 4230 |
|
|
2024
Q1 | $74.3K | Hold |
25,455
| – | – | ﹤0.01% | 4240 |
|
|
2023
Q4 | $58.8K | Buy |
25,455
+4,546
| +22% | +$10.5K | ﹤0.01% | 4311 |
|
|
2023
Q3 | $54.6K | Hold |
20,909
| – | – | ﹤0.01% | 4401 |
|
|
2023
Q2 | $74.9K | Buy |
20,909
+2,779
| +15% | +$9.95K | ﹤0.01% | 4419 |
|
|
2023
Q1 | $39.5K | Hold |
18,130
| – | – | ﹤0.01% | 4568 |
|
|
2022
Q4 | $218K | Hold |
18,130
| – | – | ﹤0.01% | 4050 |
|
|
2022
Q3 | $117K | Hold |
18,130
| – | – | ﹤0.01% | 4499 |
|
|
2022
Q2 | $83K | Sell |
18,130
-303,029
| -94% | -$1.39M | ﹤0.01% | 4651 |
|
|
2022
Q1 | $2.78M | Buy |
321,159
+75,814
| +31% | +$656K | ﹤0.01% | 3086 |
|
|
2021
Q4 | $3.5M | Sell |
245,345
-1,626
| -0.7% | -$23.2K | ﹤0.01% | 3086 |
|
|
2021
Q3 | $5.43M | Buy |
246,971
+29,263
| +13% | +$643K | ﹤0.01% | 2862 |
|
|
2021
Q2 | $2.91M | Buy |
217,708
+200,751
| +1,184% | +$2.69M | ﹤0.01% | 3154 |
|
|
2021
Q1 | $172K | Hold |
16,957
| – | – | ﹤0.01% | 4161 |
|
|
2020
Q4 | $71K | Hold |
16,957
| – | – | ﹤0.01% | 4114 |
|
|
2020
Q3 | $44K | Hold |
16,957
| – | – | ﹤0.01% | 4036 |
|
|
2020
Q2 | $59K | Hold |
16,957
| – | – | ﹤0.01% | 3953 |
|
|
2020
Q1 | $51K | Hold |
16,957
| – | – | ﹤0.01% | 3920 |
|
|
2019
Q4 | $87K | Hold |
16,957
| – | – | ﹤0.01% | 3990 |
|
|
2019
Q3 | $54K | Hold |
16,957
| – | – | ﹤0.01% | 4054 |
|
|
2019
Q2 | $60K | Buy |
+16,957
| New | +$60K | ﹤0.01% | 4059 |
|